Is TNGX Worth Buying in 2026?

Tango Therapeutics, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Tango Therapeutics, Inc. (TNGX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+14.01% over 10 days); strong 1-year return of +1981.2%; 3-month momentum positive (+104.8%). Concerns: RSI 78 — overbought, elevated pullback risk. Currently 0.6% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

TNGX is in a confirmed uptrend, trading above both its 50-day ($17.02) and 200-day ($10.47) moving averages. With an RSI of 77.9, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +1981.3% compares to +35.1% for SPY (beat the market by 1946.2%).

$10,000 invested 1 year ago → $208,125 today
vs. S&P 500 (SPY) — same period beat market by 1946.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($10.47)
Above 50-day MA ($17.02)
!RSI(14) neutral zone (30–70) — currently 77.9
Positive return (+1981.3%)
Within 10% of period high (−0.6%)
Period Range $26.64
$1.03 $26.81
RSI (14) 77.9
0 · OversoldOverbought · 100

Key Metrics

Price$26.64
Period Return+1981.3%
Period High$26.81
Period Low$1.03
Drawdown−0.6%
MA-50$17.02
MA-200$10.47
RSI (14)77.9
Avg Volume (30d)3.3M
vs. SPYbeat by 1946.2%
Return Rank#1 of 996

Trade TNGX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers